hollings renton  former president  chief executive officer at onyx pharmaceuticals inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink hollings renton former president  chief executive officer at onyx pharmaceuticals inc overview in the news relationships paths education career history boards  committees nonprofit donations  grants political donations public holdings hollings renton former president  chief executive officer at onyx pharmaceuticals inc overview age 6 born  notable companies chiron corp cetus corp onyx pharmaceuticals inc board seats  number of relationships this person is connected to  people in the news see more business wire february   zymeworks appoints dr kenneth hillan and hollings renton to its board of directors relsci october   hollings chase renton iii is no longer serving in their board position at kythera biopharmaceuticals inc marketline newswire july   anaptysbio appoints new board members pr newswire june   anaptysbio announces appointment of hollings renton and john schmid to board of directorsadds strategic planning and corporate finance expertise to board us fed news september   wipo publishes patent of genentech forma tm kenneth w bair alexandre j buckmelter kanl h clodfelter peter dragovich jian lin chase c smith zhongguo wang powai yuen mark zak xiaozhang zheng guiling zhao bingsong han xiongcai liu yamin zhang dominic j reynolds and timm r baumeister for amidobenzyl sulfone and sulfonamide derivatives american chinese inventors see full news coverage and complete stories with relsci professional create your news feed see more relationships see details william lis president chief executive officer  director at portola pharmaceuticals inc jeanjacques bienaimé chief executive officer at biomarin pharmaceutical inc dennis m fenton chief executive officer at fenton  associates llc walter h moos chief executive officer at shangpharma innovation inc laura brege managing director at cervantes life science partners llc arlene morris chairman neovacs inc at neovacs sa hamza suria president  chief executive officer at anaptysbio inc ali tehrani founder president  chief executive officer at zymeworks inc raul r rodriguez president  chief executive officer at rigel pharmaceuticals inc john l bishop former chief executive officer at cepheid see  more listings with relsci professional start my free trial ➤ see  more paths to hollings renton hollings renton you connections via relationship science hollings renton sync your contacts to see how you can connect with hollings renton start my free trial ➤ see more educational background bs in mathematics  colorado state university colorado state university is a public research university located in fort collins in the us state of colorado the university is the states land grant university and the flagship university of the colorado state university system the current enrollment is approximately  students including resident and nonresident instruction students and the university is planning on having  students by  the university has approximately  faculty in eight colleges and  academic departments bachelors degrees are offered in  fields of study with masters degrees in  fields colorado state confers doctoral degrees in  fields of study in addition to a professional degree in veterinary medicine colorado state university is a landgrant institution classified as a carnegie doctoralruvh research universities very high research activity csu was founded as colorado agricultural college in 0 six years before the colorado territory gained statehood it was one of  landgrant colleges established under the morrill act of 6 doors opened to a freshman class of  student in  mba  university of michigan  stephen m ross school of business the stephen m ross school of business at the university of michigan is a vibrant and distinctive learning community grounded in the principle that business can be an extraordinary vehicle for positive change in todays dynamic global economy at the ross school of business our mission is to develop leaders who make a positive difference in the world through thought and action members of the ross community drive change and innovation that improves business and society career history president  chief executive officer   prior onyx pharmaceuticals inc based in south san francisco california onyx pharmaceuticals inc is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer at onyx we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders innovation patientcenteredness and stewardship president  chief operating officer    chiron corp chiron corp provides nucleic acid test for blood screening its products include tigris system target capture system reagent preparation incubator and many more the company was founded in  by william j rutter edward e penhoet  pablo valenzuela and is headquartered in emeryville ca president    cetus corp boards  committees corporate boards ▾ member board of directors   current zymeworks inc zymeworks inc is a clinicalstage biopharmaceutical company which discovers develops and commercializes biotherapeutics with a focus on treatment of cancer its lead product zw is a novel bispecific antibody currently being evaluated in an adaptive phase  clinical trial the company engages in preclinical and discoverystage programs in immunooncology and other therapeutic areas zymeworks was founded by anthony fejes j haig deb farris nick bedford ali tehrani and andrew s wright in  and is headquartered in vancouver canada member board of directors   current anaptysbio inc anaptysbio inc is a biotechnology company which discovers and develops therapeutic antibodies for inflammation and immunooncology it platforms include therapeutic antibodies somatic hypermutation and shmxel the company was founded in  by andrew b cubitt william j boyle and nicholas b lydon and is headquartered in san diego ca chairman board of directors   current portola pharmaceuticals inc portola pharmaceuticals inc engages in the development and commercialization of novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation its developmentstage portfolio consists of the compounds including betrixaban a novel oral oncedaily inhibitor of factor xa in phase three clinical trials for extended duration prophylaxis or preventive treatment of a form of thrombosis known as venous thromboembolism in acute medically ill patients andexanet alfa a recombinant protein designed to reverse anticoagulant activity in patients treated with a factor xa inhibitor and cerdulatinib an orally available kinase inhibitor that inhibits spleen tyrosine kinase and janus kinases enzymes that regulate important signaling pathways the company was founded by charles j homcy and david r philips on september   and is headquartered in south san francisco ca member board of directors 0   kythera biopharmaceuticals inc kythera biopharmaceuticals inc operates as a clinicalstage biopharmaceutical company it focuses on the discovery development and commercialization of novel prescription products for the aesthetic medicine market the company was founded by jay edward birnbaum amit d munshi nathaniel eames david and keith r leonard jr on june   and is headquartered in westlake ca chairman board of directors   0 affymax inc at affymax our mission is to discover develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often lifethreatening illnesses our first marketed product omontys® peginesatide injection was approved by the us food and drug administration fda in march 0 with this approved compound we plan to establish the company as a supportive partner to physicians and patients independent nonemployee class iii director    cepheid cepheid nasdaq cphd is a leading molecular diagnostics company that is dedicated to improving healthcare by developing manufacturing and marketing accurate yet easytouse molecular systems and tests by automating highly complex and timeconsuming manual procedures the companys solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and geneticbased diseases through its strong molecular biology capabilities the company is focusing on those applications where accurate rapid and actionable test results are needed most such as managing infectious diseases and cancer chairman board of directors   prior onyx pharmaceuticals inc based in south san francisco california onyx pharmaceuticals inc is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer at onyx we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders innovation patientcenteredness and stewardship director prior sanofi genzyme genzyme corp develops and manufactures specialty therapeutic surgical and diagnostic product it serves in the areas of rare genetic diseases multiple sclerosis cardiovascular diseases and endocrinology the company was founded on june   and is headquartered in cambridge ma director prior sangstat medical corp member board of directors    rigel pharmaceuticals inc rigel pharmaceuticals inc is a clinical stage biotechnology company it discovers and develops novel targeted drugs in the therapeutic areas of immunology oncology and immune oncology the company focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms its current product development programs include fostamatinib oral syk inhibitor and r topical ophthalmic jaksyk inhibitor rigel pharmaceuticals was founded by donald g payan garry p nolan and ronald b garren on june  6 and is headquartered in south san francisco ca nonprofit boards ▾ director prior biotechnology innovation organization biotechnology innovation organization is the worlds biotechnology organization providing advocacy business development and communications services for more than  members worldwide bio members are involved in the research and development of innovative healthcare agricultural industrial and environmental biotechnology technologies corporate members range from entrepreneurial companies developing a first product to fortune  multinationals also represent state and regional biotech associations service providers to the industry and academic centers director prior special olympics of northern california nonprofit donations  grants    0 american liver foundation to facilitate and promote education support and research for the prevention and treatment of liver disease    0 american liver foundation to facilitate and promote education support and research for the prevention and treatment of liver disease     american liver foundation to facilitate and promote education support and research for the prevention and treatment of liver disease     american liver foundation to facilitate and promote education support and research for the prevention and treatment of liver disease     humane society silicon valley humane society of silicon valley is a private company headquartered in milpitas ca involved in membership organizations see  more listings with relsci professional start my free trial ➤ see  more political donations   nydia velzáquez representative from new yorks th congressional district   edward kennedy jr member attorney at epstein becker  green pc   gray davis former governor of california public holdings restricted data only for relsci professional users start my free trial ➤ see more other affiliations hollings renton is affiliated with onyx pharmaceuticals inc chiron corp cetus corp zymeworks inc anaptysbio inc portola pharmaceuticals inc kythera biopharmaceuticals inc affymax inc cepheid onyx pharmaceuticals inc sanofi genzyme sangstat medical corp rigel pharmaceuticals inc biotechnology innovation organization special olympics of northern california youve reached your 0 free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ hollings c renton chairman and lead director portola pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person hollings c renton chairman and lead director at portola pharmaceuticals location san francisco ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop hollings c renton chairman and lead director at portola pharmaceuticals location san francisco ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop mr renton brings extensive biotechnology leadership experience to kythera he has over  years of experience building successful biotechnology companies commercializing blockbuster products and forging industryleading partnerships mr renton served as the chief executive officer and president of onyx pharmaceuticals inc from  to  and as the chairman of the board from  to  from  to  he served as president and chief operating officer of chiron corporation a pharmaceutical company following its acquisition of cetus corporation prior to the acquisition he served as president of cetus corporation from 0 to  as chief operating officer from  to 0 and as chief financial officer from  to  during his tenure at cetus chiron and onyx mr renton demonstrated outstanding leadership qualities as well as a deep understanding of the opportunities and challenges faced by evolving biopharmaceutical companies he has been chairman of the board at portola pharmaceuticals inc since march  and has served as a director at cepheid inc since march  he previously served as a director of rigel pharmaceuticals inc affymax inc sangstat medical corporation special olympics northern california and the biotechnology industry organization mr renton holds an mba from the university of michigan and a bs in mathematics from colorado state university  companies in career na related markets  colleagues na related investments alias na industry pharmaceuticals tags na topics of influence web site na careers achievements investments related people edit view all hollings c rentoncareer  feb zymeworks board member mar portola pharmaceuticals chairman and lead director feb cepheid board member  to jun kythera biopharmaceuticals board member competencies edit view all hollings c rentoneducation  university of michigan  stephen m ross school of business genearl management edit hollings c rentonachievements and recognitions add milestone no milestones has been recorded for hollings c renton edit hollings c rentonlinks add link no links has been recorded for hollings c renton hollings c rentoninvestmentsacquisitions no investments has been recorded for hollings c renton hollings c rentoninvestments representing others no investment reps has been recorded for hollings c renton hollings c rentonrelated people colleagues at portola pharmaceuticals tao fu executive vice president chief commercial and business officer jun mardi c dier executive vice president chief financial officer nov william lis chief executive officer may william lis chief executive officer may view all hollings c rentonrecommended market profiles  telemedicine 0 or more employees  companies social media marketing chiefmarteccom   0 employees  companies big data universe list of lists 0 or more employees  companies aggregated marketing technology 0 or more employees 0 companies shared economy landscape jeremiah owyang 0 or more employees 6 companies inside sales landscape 0 or more employees 0 companies board of directors  portola pharmaceuticals inc menu about us executives board of directors scientific advisory board collaborations business development pipeline andexanet alfa cerdulatinib sykspecific inhibitors products bevyxxa® healthcare professionals about vte medical information requests medical education grants careers college internships total rewards program staffing agencies and recruiters media investors about usexecutives board of directors scientific advisory board collaborations business development board of directors our board of directors is considered one of the industry’s best it is comprised of leaders with a magnitude of experience in the best practices of running public companies including development commercialization operations global expansion finance and other crucial aspects of operating a successful public company jeffrey bird md phd managing director sutter hill ventures laura brege former president and chief executive officer nodality inc dennis fenton phd owner and chief executive officer fenton and associates charles homcy md former president and chief executive officer portola pharmaceuticals john h johnson founder plum brook advisors william lis chief executive officer portola pharmaceuticals hollings c renton chairman of the board david c stump md former executive vice president research and development human genome sciences inc h ward wolff executive vice president and chief financial officer sangamo biosciences inc jeffrey bird md phd managing director sutter hill ventures  jeffrey bird md phd is a managing director at sutter hill ventures where he focuses on healthcare including biotechnology and medical devices in addition to portola he is currently a board member at akarx inc cancer and hematology therapeutics macusight ophthalmic therapeutics nugen technologies research reagents restoration robotics aesthetic surgery devices roxro pharma pain therapeutics and xoft microtube cancer radiation devices he also represents the firm’s investments in acceleron pharmaceuticals metabolic therapeutics and barrx gastrointestinal devices dr bird was previously senior vice president business operations at gilead sciences where he worked from  to 0 and then from  to  he received his bs from stanford a phd in cancer biology and an md from stanford medical school back to top laura brege former president and chief executive officer nodality inc laura brege is the former president and chief executive officer of nodality inc a private company focused on innovative personalized medicine prior to joining nodality in september 0 ms brege held several seniorlevel positions at onyx pharmaceuticals inc from june 0 to december 0 including executive vice president and chief operating officer while at onyx she led multiple functions including commercialization strategic planning corporate development and medical scientific and government affairs before joining onyx ms brege was a general partner at red rock capital management a venture capital firm specializing in early stage financing for technology companies since  prior to red rock she was the senior vice president and chief financial officer at cor therapeutics earlier in her career ms brege served as vice president and chief financial officer at flextronics and vice president and treasurer of the cooper companies in addition to portola ms brege currently sits on the boards of directors of the public companies acadia pharmaceuticals inc aratana therapeutics inc and pacira pharmaceuticals inc ms brege earned her ba from ohio university honors tutorial college and an mba from the university of chicago back to top dennis fenton phd owner and chief executive officer fenton and associates dennis fenton phd is the owner and chief executive officer of fenton and associates a biotechnology consulting firm prior to founding fenton and associates dr fenton served as executive vice president of operations at amgen where he was responsible for worldwide operations manufacturing process development and quality dr fenton joined amgen in  and held numerous executive leadership roles in operations and sales and marketing in addition to portola he serves on the boards of directors of kythera biopharmaceuticals inc hospira inc dendreon corporation nora therapeutics and xenoport inc he also serves on the board of trustees of the keck graduate institute dr fenton was previously a director of the genzyme corporation genelux corporation and amira pharmaceuticals he received a bs in biology from manhattan college and a phd in microbiology from rutgers university back to top charles homcy md former president and chief executive officer portola pharmaceuticals  charles homcy md is a venture partner at third rock ventures he cofounded portola pharmaceuticals in  and served as president and chief executive officer from that time until april  prior to that he was president research and development at millennium following millennium’s acquisition of cor therapeutics in  dr homcy joined cor in  as executive vice president research and development and served as a director of the company from  to  he has been a clinical professor of medicine at the university of california san francisco medical school and attending physician at the san francisco va hospital since  he was previously president of the medical research division of american cyanamidlederle laboratories a division of wyeth dr homcy serves on the board of directors of geron corporation dr homcy received his ab and md degrees from johns hopkins university back to top john h johnson founder plum brook advisors john johnson is a recognized leader in the pharmaceutical and biotechnology industry with more than three decades of experience mr johnson has held executive management roles at leading global corporations including johnson  johnson eli lilly  company imclone and pfizer inc he recently served as a member of the board of directors of pharmaceutical research and manufacturers of america phrma and as a member of the health section governing board of the biotechnology industry organization bio he also served as chairman president and chief executive officer of dendreon corporation and as chief executive officer and a member of the board of directors of savient pharmaceuticals inc prior to these roles mr johnson served as president of eli lilly  company’s oncology unit following the company’s  acquisition of imclone systems inc where he served as chief executive officer and a member of imclone’s board of directors prior to imclone mr johnson served as the company group chairman of biopharmaceuticals within johnson  johnson where he was responsible for the johnson  johnson biotechnology immunology and oncology commercial businesses prior to that role mr johnson held several executive positions at johnson  johnson parkstone medical information systems inc orthomcneil pharmaceutical corp and pfizer inc he previously served as chairman of tranzyme pharma inc and as a member of the board of bionj mr johnson is currently a member of the board of directors of cempra inc and histogenics corporation back to top william lis chief executive officer portola pharmaceuticals  william lis joined portola in  as chief business officer and chief operating officer and was appointed chief executive officer in may  with over  years of biopharmaceutical experience under his leadership portola has advanced several novel compounds into clinical development successfully raised over  billion in private and public financings including an initial public offering in  and executed multiple partnerships for its programs mr lis previously held positions at scios inc a johnson  johnson company where he last served as vice president business and commercial operations having successfully inlicensed and led strategic development and commercial launch operations for xarelto® rivaroxaban prior to joining scios he was senior director of marketing and new products for millennium pharmaceuticals inc previously cor therapeutics inc where he managed integrilin® eptifibatide marketing and project leadership for preclinical programs earlier in his career he was involved in the us sales launch and commercialization of several products including lovenox® enoxaparin while at rhonepoulenc rorer mr lis holds a bs from the university of maryland back to top hollings c renton chairman of the board  hollings c renton previously served as president and chief executive officer director and chairman of the board of onyx pharmaceuticals inc from  to  he served as president and chief operating officer of chiron corporation a pharmaceutical company following its acquisition of cetus corporation prior to the acquisition he served as president of cetus corporation from 0 to  as chief operating officer from  to 0 and as chief financial officer from  to  mr renton currently serves as a director at cepheid inc and kythera biopharmaceuticals he previously served as a director of rigel pharmaceuticals inc affymax inc sangstat medical corporation special olympics northern california and the biotechnology industry organization mr renton holds a bs in mathematics from colorado state university and an mba from the university of michigan back to top david c stump md former executive vice president research and development human genome sciences inc  david stump md was most recently executive vice president research and development at human genome sciences inc serving there from november  until december 0 prior to joining human genome sciences dr stump held roles of increasing responsibility at genentech inc from  to  most recently as vice president clinical research and was named a genentech fellow in 6 prior to joining genentech dr stump was an associate professor of medicine and biochemistry at the university of vermont he is a member of the board of directors of sunesis pharmaceuticals inc and macrogenics inc and a member of the board of trustees of earlham college he earned an ab from earlham college and an md at indiana university followed by residency and fellowship training in internal medicine hematology and oncology and biochemistry at the university of iowa then by further postgraduate training in hemostasis and thrombosis at the university of leuven belgium he is board certified in internal medicine hematology and medical oncology and is a fellow of the american college of physicians and the council on arteriosclerosis thrombosis and vascular biology of the american heart association back to top h ward wolff executive vice president and chief financial officer sangamo biosciences inc  ward wolff was most recently executive vice president and chief financial officer of sangamo biosciences serving there from december  to march  mr wolff was formerly with nuvelo inc where he served as senior vice president finance and chief financial officer until its restructuring in august  prior to joining nuvelo he was chief financial officer and senior vice president finance of abgenix inc until april 0 when abgenix merged with amgen inc prior to joining abgenix mr wolff held financial management positions in both public and private emerging growth companies including serving as senior vice president and chief financial officer of doubletwist inc a life sciences company integrating genomic information and bioinformatics analysis tools he began his career with price waterhouse where he held a number of positions as a certified public accountant including senior audit manager mr wolff received a ba in economics from the university of california berkeley and an mba from harvard business school back to top   portola pharmaceuticals inc all rights reservedcontact us      terms of use      privacy policy renton hollings c  the wall street transcript hollings c renton hollings c renton was appointed chairman of the board of onyx pharmaceuticals in june  where he has served as president and chief executive officer since joining the company in march  prior to onyx mr renton was president and chief operating officer of chiron corporation he assumed that position in  on chiron’s acquisition of cetus corporation where he had been president since 0 and chief operating officer since  he holds an mba from the university of michigan mr renton serves as a member of the board of cepheid rigel pharmaceuticals inc the biotechnology industry organization bio and special olympics northern california related interviewshollings renton  onyx pharmaceuticals inc onyxjuly 0 hollings renton  onyx pharmaceuticals inc onxxoctober  hollings renton  onyx pharmaceuticals inc onxxjune 0 hollings renton  onyx pharmaceuticals inc onxxoctober  hollings renton  onyx pharmaceuticals onxxjune 0 hollings c renton  onyx pharmaceuticals inc onxxjanuary  hollings c renton  onyx pharmaceuticals inc onyxdecember   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover 0 ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july 0  in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu  660 wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since 6  the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google hollings renton  cepheid  email product manager  cepheidcom  phone     business card for hollings renton hollings renton product manager sunnyvale ca area cepheid 0 e caribbean dr sunnyvale ca  tel   wwwcepheidcom last updated on 00   get contact info  its free and takes 0 seconds opt out or update this contact opt out update name update title update phone update email not at this company anymore about hollings renton hollings renton works as an product manager for cepheid at sunnyvale ca the companys webpage is httpwwwcepheidcom for email phone number and executive profiles for product manager and other executives of cepheid at sunnyvale ca check cepheid at joesdatacom not the hollings renton you are looking for do a quick search in our website and find other people named hollings renton hollings rentons work history no information available hollings rentons education no information available hollings rentons coworkers as of july   hollings renton has 6 coworkers under the company name cepheid at joesdatacom about cepheid cepheid is a molecular diagnostics company that develops manufactures and markets integrated systems for testing in the clinical market as well as for application in its nonclinical biothreat industrial and partner markets its systems enable molecular testing for organisms and geneticbased diseases by automating otherwise complex manual laboratory procedures its two principal systems are the genexpert and smartcycler the genexpert system its primary offering in the clinical market integrates sample preparation in addition to deoxyribonucleic acid dna amplification and detection the genexpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations such as emergency departments and intensi source sec reports company news 0 0cepheid announces receipt of required regulatory clearances in proposed acquisition by danaher corporation00 66new bladder cancer test could reduce number of invasive procedures required for recurrence monitoring0 6cepheid announces expansion of the most comprehensive molecular c difficile product portfolio on the market0 cepheid agrees to be acquired by danaher corporation for  per share in cash0 0cepheids xpert tv now cleared for testing symptomatic and asymptomatic men0 cepheid announces partner distribution agreement with medline0 cepheid announces results of validation study for use of xpert hpv in primary cervical cancer screening0 us national tb controllers association and association of public health laboratories issue guidance for use of xpert mtbrif to support respiratory isolation decisions0 6opening of hammersmith clinic furthers the revolution in sexual health diagnostic services people in the same industry jessica baronsdirector business developmentrho incraymond ursickchief regulatory officerbioenterprise corporationsamuel whitakerfounder and board membergreenphire llcdavid grahamvp program  alliance managementaveo oncology incart blumsenior directorbiomarin pharmaceutical inckevin mcdermottvp managed marketsdaiichi sankyo company inc about us privacy terms of use work for us contact us people directory a b c d e f g h i j k l m n o p q r s t u v w x y z company directory a b c d e f g h i j k l m n o p q r s t u v w x y z copyright   joesdatacom all rights reserved hollings renton  onyx pharmaceuticals  inc  zoominfocom hollings renton  directors and boards skip to main content login username  password  go  forgot password not a subscriber search form search toggle navigation mr hollings c rentonfrom  until his retirement in  he was chairman of onyx pharmaceuticals inc where he previously served as president and ceo from  he had also served as president and coo of chiron corp which in  acquired cetus corp where he had been president and coo second quarteradded to affymax inc  palo alto caaffymax is a biopharmaceutical company with a lead product candidate for the treatment of anemia revenues are  million zymeworks appoints dr kenneth hillan and hollings renton to its board of directors  business wire zymeworks appoints dr kenneth hillan and hollings renton to its board of directors dr donald drakeman transitions to advisor february   0 am eastern standard time vancouver canadabusiness wirezymeworks inc “zymeworks” a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration multifunctional biotherapeutics initially focused on the treatment of cancer today announced that dr kenneth hillan ceo of achaogen inc and hollings renton former ceo and president of onyx pharmaceuticals inc have been appointed to zymeworks’ board of directors concurrent with the appointment of dr hillan and mr renton zymeworks also announces that dr donald drakeman has retired from the company’s board of directors and is transitioning to the position of special advisor to zymeworks and the board of directors dr drakeman will continue to contribute his knowledge and perspective to zymeworks’ management and the board of directors “we are delighted to welcome kenneth and hollings to our board of directors” said ali tehrani phd zymeworks’ president  ceo “their collective experience working at the highest levels of the biotech and pharmaceutical industries will provide zymeworks with valuable guidance as we move our lead product candidate zw through clinical trials and our preclinical assets closer to the clinic we would also like thank don for his service on the board since  we look forward to continuing to benefit from his expertise as advisor to zymeworks” “zymeworks’ nextgeneration therapies aim to advance the practice of medicine and make patients’ lives better which is one of the most important contributions we can make to the healthcare challenges we face today” said dr hillan “i look forward to working with the board members and the zymeworks leadership team to support the company’s mission of creating biotherapeutics that allow patients to return home to their loved ones disease free” mr renton added “i am very pleased to join zymeworks’ board of directors and to work with the team to advance their versatile bispecific antibody capabilities zymeworks is wellpositioned with their lead product candidate in clinical trials and an exciting preclinical pipeline” dr kenneth j hillan is the ceo of achaogen inc he has served as ceo and a member of the board of directors of achaogen since october 0 prior to joining achaogen dr hillan worked at genentech inc a pharmaceutical company and a member of the roche group dr hillan worked in progressively senior roles after joining genentech in  he was responsible for numerous successful drug approvals and led the medical and scientific strategies for genentech’s immunology tissue growth and repair drug portfolio dr hillan also served on the board of directors of relypsa inc a publicly traded biotechnology company that was acquired in  by galencia ag for  billion dr hillan has an mb chb bachelor of medicine and surgery degree from the faculty of medicine at the university of glasgow in the united kingdom dr hillan is a fellow of the royal college of surgeons and a fellow of the royal college of pathologists dr hillan has authored dozens of scientific publications and is a named inventor on approximately 0 issued patents hollings renton served as ceo and president of onyx pharmaceuticals inc from  to  and was the chairperson of the board of directors of onyx from  to  onyx was acquired by amgen inc in  for 0 billion before joining onyx mr renton was the president and chief operating officer of chiron corporation a pharmaceutical company mr renton served in a variety of executive roles at cetus corporation from  prior to its acquisition by chiron in  mr renton currently serves as chairperson of the board of directors of portola pharmaceuticals inc and on the board of directors of anaptysbio inc mr renton received his mba from the university of michigan and his bs in mathematics from colorado state university about zymeworks inc zymeworks is a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration multifunctional biotherapeutics initially focused on the treatment of cancer zymeworks’ suite of complementary therapeutic platforms and its fullyintegrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highlydifferentiated product candidates zymeworks’ lead product candidate zw is a novel bispecific antibody currently being evaluated in an adaptive phase  clinical trial zymeworks is also advancing a deep pipeline of preclinical product candidates and discoverystage programs in immunooncology and other therapeutic areas in addition to zymeworks’ whollyowned pipeline its therapeutic platforms have been further leveraged through multiple strategic partnerships with global biopharmaceutical companies contacts zymeworks incinvestor inquiriesdavid matousek 606senior manager investor relations  corporate communicationsirzymeworkscom contacts zymeworks incinvestor inquiriesdavid matousek 606senior manager investor relations  corporate communicationsirzymeworkscom search advanced news search advanced news search log in sign up   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied hollings renton  portland or  intelius sign in we found hollings renton in portland or hollings renton intelius found that hollings renton is a male between 0 and 0 years old from portland or we have connected them to 6 addresses  phones and  relatives or associates also known as hollings chase renton h c renton get report now age hollings renton is in his 0s hollings has lived in portland or sunnyvale ca bend or hollingss relatives alexa scholz mary renton chase renton hollings renton zodiac signscorpio gendermale professional status member board of directors at cepheid incorporated get report now want to know more about hollings get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about hollings or use our people search engine to find others get background check on hollings renton get a criminal check on hollings renton get a public record report on hollings renton get a people search report on hollings renton hollings rentons contact information known cities lived in find out where hollings renton has lived as well as hollings rentons phone numbers and email addresses hollings renton has lived in  states oregon address for hollings renton 0 n c s portland or has lived in portland or sunnyvale ca get full address report phone numbers associated with hollings renton    portland or 60   rancho mirage ca    orinda ca get full phone report email addresses associated with hollings renton hncom hnnet hncom get email report hollings rentons education information known schools attended learn about hollings rentons academic history find out which schools hollings renton attended the dates attended as well as the degrees hollings renton received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act hollings renton has attended  schools university of michigan  stephen m ross school of business  –  hollings renton has a mba in genearl management university of michigan  stephen m ross school of business  –  hollings renton has a mba genearl management in genearl management hollings rentons professional information information regarding hollings rentons professional history find out previous places hollings renton has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act hollings renton has worked at  places company cepheid incorporated title member board of directors company portola pharmaceuticals  inc title cochairman and lead director hollings rentons experience title member board of directors company cepheid incorporated job details company size 0 mil to less than  mil  employee range  to less than  title cochairman and lead director company portola pharmaceuticals  inc job details company size 0 mil to less than  mil  employee range  to less than  additional professional information on hollings renton see hollings rentons linkedin profile hollings rentons social network and potential email matches find out potential social network profiles and potential email usernamed for hollings renton hollings rentons known social networks and potential email matches find all of hollings rentons social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches hollings renton username matches hollingsrenton rentonhollings hollingsrenton rentonhollings hollingsrenton rentonhollings hollingsrenton rentonhollings hrenton popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches h renton intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here